Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Opticin may contribute to the antiangiogenic properties of the vitreous humor

May 10, 2006

Novel neuroprotective strategies in glaucoma therapeutics - Part I

May 9, 2006

Snapshots on novel therapeutic strategies for choroidal neovascularization

May 8, 2006

Geranylgeranyltransferase type I, a potential therapeutic target in glaucoma

May 8, 2006

The marine product misakinolide A could be useful in glaucoma therapy

May 8, 2006

Preclinical data on antioxidant drugs for AMD reported by Othera

May 5, 2006

Small alpha5beta1 integrin inhibitor reduces choroidal neovascularization in different animal models

May 5, 2006

Snapshots of recent studies on VEGF Trap presented at the ARVO meeting

May 4, 2006

Silencing RTP801 gene with novel siRNA shows benefit in a murine model of CNV

May 4, 2006

RTK inhibition reduces retinal vascular permeability in animal models of diabetic macular edema

May 4, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Beone eyes Huahui Health’s trispecific HH-160 with $2B option deal
BioWorld
Beone Medicines Ltd. gained an exclusive option to develop cancer immunotherapy HH-160 worldwide in a deal potentially worth more than $2 billion for Huahui...
Unique trial strategy muddies the ODAC waters for camizestrant
BioWorld
Following a discussion that focused more on a new personalized trial strategy rather than the proposed therapy, the U.S. FDA’s Oncologic Drugs Advisory Committee...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...